...
【24h】

Response to Smith

机译:对史密斯的回应

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Dr. Smith asks an important question, namely if "D-cycloserine augmentation of virtual reality exposure therapy appeared to be associated with worse outcomes for the subset of patients experiencing little response or worsening of subjective distress during the treatment." The figure and analysis to which Dr. Smith refers are implied from a mixed-effect model that included all participants (N=156). Different outcomes were discovered based on different measures in this study. The most robust beneficial effects of D-cycloserine were seen in the more objective measures of psychophysiological startle and salivary cortisol, consistent with the animal literature on the facilitation of extinction by D-cycloserine. Less consistent were the posttraumatic stress disorder (PTSD) clinical measures that were all based on patient self-report. Even though the Clinician Administered PTSD Scale is a clinical interview, it is based on patient self-report of PTSD symptoms. Even more subjective is the Subjective Units of Distress Scale, which the analysis of emotional learning within and between sessions (to which Dr. Smith refers) is based.
机译:史密斯博士提出了一个重要问题,即“对于在治疗过程中几乎没有反应或主观困扰加重的患者亚群,D-环丝氨酸增强虚拟现实暴露疗法是否似乎与较差的预后相关”。史密斯博士提到的数字和分析是从包括所有参与者(N = 156)的混合效应模型中得出的。在这项研究中,基于不同的措施发现了不同的结果。在更客观的心理生理惊吓和唾液皮质醇测定中,可以看到D-环丝氨酸的最强效作用,这与动物文献对D-环丝氨酸的灭绝有促进作用。创伤后应激障碍(PTSD)临床测量的一致性较差,这些临床测量均基于患者的自我报告。即使临床医生管理的PTSD量表是一项临床访谈,它仍基于患者的PTSD症状自我报告。更为主观的是“主观痛苦单位量表”,它是分析会议期间和会议之间(史密斯博士所指的)的情绪学习的基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号